Article info
Student essay
Should vaccination status be a consideration during secondary triage?
- Correspondence to Isaac Jarratt Barnham, Pembroke College, University of Oxford, Oxford, UK; icjb1{at}hotmail.co.uk
Citation
Should vaccination status be a consideration during secondary triage?
Publication history
- Received June 26, 2023
- Accepted November 12, 2023
- First published November 29, 2023.
Article Versions
- Previous version (22 January 2024).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- COVID-19 vaccine hesitancy and vaccine passports: a cross-sectional conjoint experiment in Japan
- Determinants of COVID-19 vaccine hesitancy and uptake in sub-Saharan Africa: a scoping review
- Vaccine hesitancy from the parent perspectives: protocol for a qualitative study in Iran
- Assessing vaccine hesitancy in Arab countries in the Middle East and North Africa (MENA) region: a scoping review protocol
- Oxford Vaccine Hesitancy Scale (OVHS): a UK-based and US-based online mixed-methods psychometric development and validation study of an instrument to assess vaccine hesitancy
- Understanding non-vaccinating parents’ views to inform and improve clinical encounters: a qualitative study in an Australian community
- The language of vaccination campaigns during COVID-19
- Current tools available for investigating vaccine hesitancy: a scoping review protocol
- Exploring COVID-19 vaccine uptake, confidence and hesitancy among people experiencing homelessness in Toronto, Canada: protocol for the Ku-gaa-gii pimitizi-win qualitative study
- Perspectives of primary care physicians on acceptance and barriers to COVID-19 vaccination